Case Control Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Jan 15, 2020; 12(1): 77-82
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.77
Figure 1
Figure 1 Abnormal FDG uptake on positron emission tomography. A: Computed tomography scan of the abdomen showing enlarged hepatic LN; B: Positron emission tomography showing abnormal FDG uptake in the same LN. FDG: Fluorodeoxyglucose; LN: Lymph node.